EPA Investigates Benzene Problems at BP Texas City Refinery

Federal environmental regulators have launched an investigation into benzene problems at BP’s Texas City oil refinery, a facility that has already racked up hundreds of millions of dollars in government fines and court judgments for disregarding environmental regulations and safety failures that have resulted in injuries and deaths. 

Last Thursday, the U.S. Environmental Protection Agency (EPA) announced that it was looking into what it calls a “catastrophic” release of benzene, a known carcinogen, for 41 days in April and May, 2010. The release occurred after a hydrogen compressor broke down on April 6, and put half a million pounds of total pollutants into the air, 17,000 pounds of which was benzene, according to BP.

BP already faces a $10 billion toxic tort class action lawsuit over the benzene release that was filed by more than 2,200 workers at the refinery and residents from the surrounding area. The lawsuit was filed in August in U.S. District Court in the Galveston Division for the Southern District of Texas. The plaintiffs allege that they suffered serious injuries and illnesses from benzene exposure.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

The Texas Attorney General’s Office has also promised to bring a claim against the company.

“By joining the investigation, EPA will help ensure disclosure of all information by BP,” said Al Armendariz, EPA Regional Administrator for Region 6, in an EPA press release. “It is important the EPA, state officials and public know what happened at the plant, and that BP is held accountable to prevent incidents like these from happening in the future.”

BP’s Texas City Refinery is the third-largest oil refinery in the United States, and has been the subject of several major safety incidents. As recently as September, the U.S. Occupational Safety and Health Administration hit BP with an $87.4 million fine for not complying with a safety agreement made after a March 23, 2005 explosion and fire that killed 15 workers and injured more than 170 others.

In February 2009, BP Products North America agreed to pay $180 million to resolve a separate environmental lawsuit over benzene emissions at the refinery. That case involved violations of a 2001 consent decree and Clean Air regulations which were identified during inspections by the U.S. Environmental Protection Agency (EPA) following the March 2005 blast.

Under the terms of that settlement, BP agreed to spend $161 million to address their Clean Air Act violations by setting up better pollution controls, enhanced maintenance and monitoring devices and improving their internal management practices. Another $6 million was designated to fund a project to reduce air pollution in Texas City and $12 million was paid as a penalty.

Benzene is an industrial chemical that has been associated with the development of several fatal forms of cancer, leukemia and other conditions, such as Acute Myelogenous Leukemia (AML), Chronic Myelogenous Leukemia (CML), Acute Lymphocytic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL), Hairy Cell Leukemia (HCL), Non-Hodgkin’s Lymphoma, Multiple Myeloma, Myelodysplastic Syndrome (MDL), Myelofibrosis and Myeloid Metaplasia, Aplastic Anemia and Thrombocytopenic Purpura.

1 Comments

  • CARLNovember 15, 2010 at 9:58 pm

    I;m having trouble breathing, I get short winded very easily and I no longer have a since of smell. I can't smell anything.

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted 2 days ago)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 3 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 4 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.